297.89
price up icon0.16%   0.49
 
loading
Schlusskurs vom Vortag:
$297.40
Offen:
$297.72
24-Stunden-Volumen:
2.52M
Relative Volume:
1.14
Marktkapitalisierung:
$160.37B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$6.62B
KGV:
24.37
EPS:
12.223
Netto-Cashflow:
$10.61B
1W Leistung:
+9.13%
1M Leistung:
+4.95%
6M Leistung:
-3.86%
1J Leistung:
-6.17%
1-Tages-Spanne:
Value
$295.63
$301.54
1-Wochen-Bereich:
Value
$270.67
$301.66
52-Wochen-Spanne:
Value
$253.30
$335.88

Amgen Inc Stock (AMGN) Company Profile

Name
Firmenname
Amgen Inc
Name
Telefon
(805)447-1000
Name
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Mitarbeiter
28,000
Name
Twitter
@amgen
Name
Nächster Verdiensttermin
2025-02-04
Name
Neueste SEC-Einreichungen
Name
AMGN's Discussions on Twitter

Vergleichen Sie AMGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
AMGN
Amgen Inc
297.89 160.11B 34.76B 6.62B 10.61B 12.22
Drug Manufacturers - General icon
LLY
Lilly Eli Co
839.87 734.96B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
188.64 447.90B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
233.91 417.90B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
132.39 253.54B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
89.19 223.58B 63.43B 16.42B 14.72B 6.4861

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-03 Fortgesetzt Raymond James Mkt Perform
2025-05-20 Fortgesetzt Guggenheim Neutral
2025-04-22 Fortgesetzt Cantor Fitzgerald Neutral
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-14 Eingeleitet Citigroup Neutral
2024-10-17 Eingeleitet Bernstein Outperform
2024-10-14 Herabstufung Truist Buy → Hold
2024-09-27 Eingeleitet Cantor Fitzgerald Overweight
2024-08-07 Herabstufung Wells Fargo Overweight → Equal Weight
2024-05-03 Hochstufung Barclays Underweight → Equal Weight
2024-05-03 Hochstufung William Blair Mkt Perform → Outperform
2024-03-28 Fortgesetzt Raymond James Mkt Perform
2024-02-07 Herabstufung Leerink Partners Outperform → Market Perform
2023-12-21 Hochstufung Daiwa Securities Neutral → Buy
2023-12-19 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-12-12 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Hold
2023-11-02 Hochstufung Truist Hold → Buy
2023-10-20 Fortgesetzt JP Morgan Neutral
2023-10-17 Fortgesetzt Morgan Stanley Equal-Weight
2023-10-11 Fortgesetzt BofA Securities Neutral
2023-09-06 Eingeleitet HSBC Securities Buy
2023-04-24 Bestätigt Oppenheimer Outperform
2023-03-13 Hochstufung Wells Fargo Equal Weight → Overweight
2023-02-13 Bestätigt Truist Buy
2022-11-18 Eingeleitet Credit Suisse Underperform
2022-10-31 Herabstufung Barclays Equal Weight → Underweight
2022-10-11 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-05-23 Eingeleitet SVB Leerink Mkt Perform
2022-02-09 Bestätigt Barclays Equal Weight
2022-02-09 Bestätigt Jefferies Buy
2022-02-09 Bestätigt Morgan Stanley Equal-Weight
2022-02-09 Bestätigt Oppenheimer Outperform
2022-02-09 Bestätigt Wells Fargo Equal Weight
2022-01-05 Herabstufung BofA Securities Buy → Neutral
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-12-06 Eingeleitet Goldman Buy
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-09-23 Herabstufung Daiwa Securities Outperform → Neutral
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-29 Eingeleitet Daiwa Securities Buy
2020-10-28 Eingeleitet UBS Neutral
2020-10-26 Hochstufung Raymond James Mkt Perform → Outperform
2020-10-12 Hochstufung Truist Hold → Buy
2020-10-09 Herabstufung Bernstein Outperform → Mkt Perform
2020-10-09 Herabstufung Truist Buy → Hold
2020-10-08 Herabstufung Raymond James Outperform → Mkt Perform
2020-04-15 Fortgesetzt Guggenheim Neutral
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-03-30 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-05 Hochstufung BofA/Merrill Neutral → Buy
2020-02-27 Eingeleitet Barclays Equal Weight
2020-01-31 Herabstufung Robert W. Baird Neutral → Underperform
2020-01-21 Hochstufung Evercore ISI In-line → Outperform
2019-12-24 Eingeleitet Raymond James Mkt Perform
2019-12-17 Fortgesetzt Morgan Stanley Overweight
2019-11-12 Eingeleitet SunTrust Buy
2019-11-05 Hochstufung Cantor Fitzgerald Neutral → Overweight
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-19 Herabstufung Mizuho Buy → Neutral
2019-05-23 Hochstufung Citigroup Neutral → Buy
Alle ansehen

Amgen Inc Aktie (AMGN) Neueste Nachrichten

pulisher
06:47 AM

Should I buy Amgen Inc. (AMG0) stock before earnings seasonPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com

06:47 AM
pulisher
05:18 AM

Amgen Inc. $AMGN Shares Acquired by O Keefe Stevens Advisory Inc. - MarketBeat

05:18 AM
pulisher
05:08 AM

Amgen Inc. $AMGN Shares Sold by Boston Common Asset Management LLC - MarketBeat

05:08 AM
pulisher
05:04 AM

Amgen Inc. $AMGN Stock Position Lifted by Talbot Financial LLC - MarketBeat

05:04 AM
pulisher
04:36 AM

Ameriflex Group Inc. Cuts Stock Position in Amgen Inc. $AMGN - MarketBeat

04:36 AM
pulisher
04:22 AM

Amgen Inc. $AMGN Shares Sold by Ascent Group LLC - MarketBeat

04:22 AM
pulisher
04:18 AM

Ameritas Advisory Services LLC Has $1.23 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

04:18 AM
pulisher
12:40 PM

How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com

12:40 PM
pulisher
Oct 04, 2025

(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Oct 04, 2025
pulisher
Oct 04, 2025

(AMGN) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Oct 04, 2025
pulisher
Oct 04, 2025

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs - MSN

Oct 04, 2025
pulisher
Oct 04, 2025

Trading the Move, Not the Narrative: (AMGN) Edition - news.stocktradersdaily.com

Oct 04, 2025
pulisher
Oct 04, 2025

AMF Tjanstepension AB Grows Stake in Amgen Inc. $AMGN - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

4 Reasons to Buy Amgen Stock Right Now - Nasdaq

Oct 04, 2025
pulisher
Oct 04, 2025

QRG Capital Management Inc. Increases Position in Amgen Inc. $AMGN - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Corundum Group Inc. Grows Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Amgen Inc. $AMGN Stock Position Lifted by Precedent Wealth Partners LLC - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Franklin Street Advisors Inc. NC Sells 21,044 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

The Technical Signals Behind (AMGN) That Institutions Follow - news.stocktradersdaily.com

Oct 04, 2025
pulisher
Oct 04, 2025

Sen. Sheldon Whitehouse Sells Amgen Inc. (NASDAQ:AMGN) Stock - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Amgen (NASDAQ:AMGN) Upgraded to Buy at Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

(AMGN) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Oct 03, 2025
pulisher
Oct 03, 2025

(AMGN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Oct 03, 2025
pulisher
Oct 03, 2025

Colorado Adopts First State Payment Cap for Amgen’s Enbrel (1) - Bloomberg Law News

Oct 03, 2025
pulisher
Oct 03, 2025

Cramer's Stop Trading: Amgen - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

How (AMGN) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Oct 03, 2025
pulisher
Oct 03, 2025

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

Greenwood Capital Associates LLC Sells 5,673 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Amgen Inc. $AMGN Shares Purchased by Mattern Capital Management LLC - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Hilltop National Bank Makes New Investment in Amgen Inc. $AMGN - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Amgen stock maintains Outperform rating at Oppenheimer after positive Repatha trial - Investing.com

Oct 03, 2025
pulisher
Oct 03, 2025

Amgen Inc. $AMGN Stock Position Lifted by Mirae Asset Global Investments Co. Ltd. - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Amgen (AMGN) Is Up 9.7% After Repatha Trial Success and Puerto Rico Expansion Announcement – What's Changed - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Amgen Inc. $AMGN Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Is Amgen Inc. (AMG0) stock a buy for dividend portfoliosJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Amgen Inc. (AMG0) stock extend growth story2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Amgen Inc. price bounce be sustainable2025 Biggest Moves & Smart Money Movement Tracker - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why global investors buy Amgen Inc. (AMG0) stockPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What data driven models say about Amgen Inc.’s futureJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com

Oct 02, 2025
pulisher
Oct 02, 2025

Short interest data insights for Amgen Inc.Weekly Profit Recap & AI Driven Price Forecasts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Primary-Prevention Data Should Boost Uptake Of Amgen’s Repatha - insights.citeline.com

Oct 02, 2025
pulisher
Oct 02, 2025

Responsive Playbooks and the AMGN Inflection - news.stocktradersdaily.com

Oct 02, 2025
pulisher
Oct 02, 2025

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap - Benzinga

Oct 02, 2025
pulisher
Oct 02, 2025

Cartography Bio maps out cancer drug plan with $67 million from Pfizer, Amgen venture units and more - The Business Journals

Oct 02, 2025
pulisher
Oct 02, 2025

Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings - FinancialContent

Oct 02, 2025
pulisher
Oct 02, 2025

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise - Yahoo Finance

Oct 02, 2025
pulisher
Oct 02, 2025

Amgen claims ‘landmark’ study result that could widen heart drug’s use - BioPharma Dive

Oct 02, 2025
pulisher
Oct 02, 2025

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term - sharewise.com

Oct 02, 2025
pulisher
Oct 02, 2025

(AMGN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Oct 02, 2025
pulisher
Oct 02, 2025

Amgen (AMGN) Hits Key Milestones with Repatha in Cardiovascular Trial - GuruFocus

Oct 02, 2025

Finanzdaten der Amgen Inc-Aktie (AMGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general PFE
$27.37
price up icon 1.07%
$112.69
price up icon 1.93%
drug_manufacturers_general SNY
$50.90
price up icon 1.52%
drug_manufacturers_general NVO
$59.63
price up icon 1.52%
drug_manufacturers_general MRK
$89.19
price down icon 0.36%
Kapitalisierung:     |  Volumen (24h):